PRINCETON, N.J., March 25 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, today announced that MEDIHONEY(TM) Wound & Burn Dressing, its flagship wound care product, has been the subject of several recent television news health segments.
Washington NBC affiliate News 4 chronicled a Georgetown University pilot program that is evaluating MEDIHONEY for wound care. http://video.nbc4.com/player/?id=231798
Philadelphia Fox affiliate WTFX chronicled a similar program at Temple University Hospital. http://www.myfoxphilly.com/myfox/pages/ContentDetail?contentId=5844139
The physician interviewed from Georgetown University is Dr. Christopher Attinger, MD. Dr. Attinger is the director of the Wound Healing Center at Georgetown University Hospital, is a co-chairperson of the annual Diabetic Limb Salvage conference, and in 2007 received the Edward James Olmos Award for Advocacy in Amputation Prevention from DF Con, a global conference on issues surrounding the diabetic foot.
The physician interviewed from Temple University is Dr. James McGuire, PT, DPM. Dr. McGuire is the Chairperson of the Department of Podiatric Medicine and Orthopedics at the Temple University School of Podiatric Medicine, and is also the Director of the Leonard S. Abrams Center for Advanced Wound Healing at Temple University's Foot and Ankle Institute.
The opinions expressed in the segments are those of the television stations and of the persons interviewed. The information in the segments contains uses that have not been cleared by the US Food and Drug Administration.
About Derma Sciences
Derma Sciences is a global manufacturer and marketer of advanced
wound-care products. Its key product, MEDIHONEY, is sold throughout the
world by Derma Sciences and Comvita New Zealand -- the licensor of the
patented honey-based technology -- and is the leading brand of honey-based
dressings for the management of wounds and burns. The product has been
shown to be effective in a variety of wounds and burns, and was recently
the focus of two positive large-scale randomized controlled studies on leg
ulcers. For more information about Derma Sciences, Inc., visit its home
page on the Internet at http://www.dermasciences.com.
Contact: Derma Sciences Inc Allen & Caron Inc
Edward J. Quilty Rudy Barrio (US Investors)
Chairman and CEO email@example.com
firstname.lastname@example.org (212) 691-8087
|SOURCE Derma Sciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved